Oragenics (OGEN)
(Real Time Quote from BATS)
$1.26 USD
+0.01 (0.80%)
Updated Aug 4, 2025 01:06 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OGEN 1.26 +0.01(0.80%)
Will OGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for OGEN
Oragenics (OGEN) Selects CRO for Phase IIa Trial of Concussion Drug
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase ...
Oragenics (OGEN) Secures Manufacturing Deal for Key Drug Candidate | OGEN Stock News
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical ...